Home
Board & C-Suite Retained Search
Retained Search – Overview
Retained Search – Case Studies
Executive Interims
Executive Interims – Overview
Executive Interims – Case Studies
People & Organisation Advisory
People & Organisation Advisory – Overview
People & Organisation Advisory – Case Studies
Our Story
40th Wall of Fame
History
The Building Blocks
Meet Us
News & Views
RSA Viewpoints
RSA Talent Equity®
RSA News
Events
Contact
Contact
Careers at RSA
Candidates
Site Search
Retained Search
Case Studies
Executive Interims
Case Studies
People & Organisation Advisory
Case Studies
Our Team
RSA Viewpoints
Categories
RSA Viewpoints
RSA Talent Equity®
RSA News
Events
Archives
Archives
Select Month
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
August 2019
July 2019
June 2019
May 2019
March 2019
February 2019
January 2019
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
July 2015
June 2015
May 2015
April 2015
February 2015
December 2014
December 2013
Search for:
RSA Group Lands CEO for Biotec Pharmacon ASA
Posted on 5th October 2017 -
RSA Viewpoints
Share this:
Identifying, attracting, and retaining top talent in the biosimilars space
Rise of the centenarians
Accelerating advanced therapies to market
Identifying, attracting, and retaining top talent in the biosimilars space
Rise of the centenarians
More news